MtDNA repair: An isolated pharmacologic target in acute lung injury
MtDNA 修复:急性肺损伤的一个孤立的药理学靶点
基本信息
- 批准号:10206228
- 负责人:
- 金额:$ 41.84万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2012
- 资助国家:美国
- 起止时间:2012-04-16 至 2023-06-30
- 项目状态:已结题
- 来源:
- 关键词:AcuteAcute Lung InjuryAddressAdult Respiratory Distress SyndromeAnimal ModelAutomobile DrivingAwardBacteriaBioenergeticsBiologicalBiologyCharacteristicsClinicalCritical IllnessDNA Repair EnzymesDNA receptorDevelopmentDiseaseDisease ProgressionDistantEnvironmentEventEvolutionFractureFunctional disorderGenerationsGoalsHumanHyperoxiaInflammatoryInjuryLaboratoriesLeadLinkLungLung TransplantationMitochondriaMitochondrial DNAMolecularMultiple Organ FailureNew AgentsObservational StudyOrganOutcomeOxidantsOxidative StressPathogenesisPathway interactionsPatientsPatternPattern FormationPharmacologyPlasmaPre-Clinical ModelProcessProductionReperfusion InjuryReportingResearchRiskSentinelSiteSomatic MutationSourceStressTestingTransfusionTransplantationTrauma patientVentilatorautoinflammatorybaseblood productclinical biomarkerscytokinecytotoxicityextracellularhuman subjectinnovationinsightlung injurymitochondrial DNA mutationmitochondrial dysfunctionmitochondrial genomeoperationoutcome predictionoxidative damagepreventregenerativerepairedresponseresponse to injurysevere injurytrafficking
项目摘要
PROJECT SUMMARY/ABSTRACT
Mitochondrial (mt) dysfunction is common in the Acute Respiratory Distress Syndrome and its sequel, Multiple
Organ System Failure, but the potential for mt-associated pathways to serve as pharmacologic targets in
ARDS and MOSF has yet to be realized. Among the discoveries originating from this project, two lines of
evidence may have paradigm-shifting implications. First, modulation of mtDNA repair coordinately regulates
oxidative mtDNA damage and attendant cytotoxicity. And second, fragmentation of oxidatively damaged
mtDNA into Damage Associated Molecular Patterns may disseminate injury to distant organs by activating a
regenerative, feed-forward pathway in which mtDNA DAMPs, themselves, damage the mitochondrial genome
and promote more mtDNA DAMP formation. These considerations provide the underpinnings for our long-
term goal to develop pharmacologic strategies to treat ARDS and MOSF based on the concept that
mitochondrial (mt) DNA acts as a molecular sentinel governing disease progression in response to
critical illness or injury. Motivated by our finding that administration of transfusion products inadvertently
containing variable amounts of mtDNA DAMPs increases circulating mtDNA DAMP levels and elevates the risk
of ARDS-like Transfusion Related Acute Lung Injury in severely injured patients, Aim 1 will determine if a
feed-forward pathway contributes to mtDNA DAMP accumulation in massively-transfused, critically
injured human subjects at risk for TRALI. Here, we will test the hypothesis that the amount of exogenous
mtDNA administered during massive transfusion dictates the amount of mtDNA DAMPs mobilized from
endogenous, patient-derived sources. The second Aim is predicated on the fact that although oxidative mtDNA
damage leads to DAMP release, only scant information is available concerning mechanisms of mtDNA
fragmentation and sequence characteristics of the DAMPs so formed. Indeed, such deficiencies present
serious obstacles to addressing fundamental questions pertaining to which mtDNA fragments are biologically
active and how they are trafficked in the intra- and extracellular environments. Accordingly, Aim 2 will test the
hypothesis that sites of oxidative damage to the mitochondrial genome promote its fracture into
specific mtDNA DAMP sequences and predispose the mt-genome to somatic mutation. Collectively, the
proposed research is significant because it will provide insight into the mechanisms of mtDNA DAMP
formation, the importance of mtDNA DAMPs in the response to injury, and their utility as a pharmacologic
target. It is innovative because the postulated operation of feedforward pathway involving mtDNA damage-
induced DAMP formation is a fundamentally new concept to explain the progressive pathogenesis of ARDS
and MOSF.
项目摘要/摘要
线粒体(MT)功能障碍在急性呼吸窘迫综合征及其续集中常见
器官系统故障,但与MT相关途径的潜力是作为药理目标
Ards和MOSF尚未实现。在来自该项目的发现中,两行
证据可能具有范式转移的含义。首先,MTDNA修复的调节协调调节
氧化mtDNA损伤和随之而来的细胞毒性。其次,氧化损坏的碎片化
mtDNA进入损伤相关的分子模式可能会通过激活A传播对遥远器官的损伤
再生,喂养前途径,其中mtDNA潮湿损坏了线粒体基因组
并促进更多mtDNA潮湿的形成。这些考虑为我们的长期提供了基础
基于以下概念来制定药理策略来治疗ARD和MOSF的术语目标
线粒体(MT)DNA充当疾病进展的分子前哨
重症或受伤。由于我们发现输血产品的管理无意
含有可变量的mtDNA潮湿会增加循环的mtDNA湿水平并提高风险
严重受伤的患者的ARDS样输血相关的急性肺损伤,AIM 1将确定是否a
进料前途径有助于mtDNA潮湿在大规模转移的,批判性的
受伤的人的受试者有Trali的风险。在这里,我们将测试外源量的假设
在大规模输血期间给药的mtDNA决定了从
内生,患者衍生的来源。第二个目的是基于以下事实:尽管氧化mtDNA
损坏导致潮湿释放,仅提供有关mtDNA机制的信息很少
潮湿的碎片和序列特征如此形成。确实,这种缺陷存在
解决与哪些碎片是生物学上有关的基本问题的严重障碍
活跃以及它们如何被贩运在细胞内和细胞外环境中。因此,AIM 2将测试
假设线粒体基因组氧化损伤部位促进其裂缝
特定的mtDNA湿序序列,使MT基因组易于体细胞突变。集体,
拟议的研究很重要,因为它将洞悉mtDNA潮湿的机制
形成,mtDNA潮湿在对损伤的反应中的重要性以及它们作为药理的实用性
目标。这是创新的,因为涉及mtDNA损坏的前馈途径的假设操作 -
诱导的潮湿形成是一种从根本上解释ARDS进行性发病机理的新概念
和MOSF。
项目成果
期刊论文数量(13)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Elevated levels of plasma mitochondrial DNA DAMPs are linked to clinical outcome in severely injured human subjects.
- DOI:10.1097/sla.0b013e3182a4ea46
- 发表时间:2013-10
- 期刊:
- 影响因子:9
- 作者:Simmons JD;Lee YL;Mulekar S;Kuck JL;Brevard SB;Gonzalez RP;Gillespie MN;Richards WO
- 通讯作者:Richards WO
Pharmacologic Protection of Mitochondrial DNA Integrity May Afford a New Strategy for Suppressing Lung Ischemia-Reperfusion Injury.
- DOI:10.1513/annalsats.201706-438mg
- 发表时间:2017-09
- 期刊:
- 影响因子:8.3
- 作者:Yong B. Tan;S. Mulekar;O. Gorodnya;M. Weyant;M. Zamora;J. Simmons;Tiago Machuka;M. Gillespie
- 通讯作者:Yong B. Tan;S. Mulekar;O. Gorodnya;M. Weyant;M. Zamora;J. Simmons;Tiago Machuka;M. Gillespie
Potential contribution of mitochondrial DNA damage associated molecular patterns in transfusion products to the development of acute respiratory distress syndrome after multiple transfusions.
- DOI:10.1097/ta.0000000000001421
- 发表时间:2017-06
- 期刊:
- 影响因子:0
- 作者:Simmons JD;Lee YL;Pastukh VM;Capley G;Muscat CA;Muscat DC;Marshall ML;Brevard SB;Gillespie MN
- 通讯作者:Gillespie MN
Mitochondrial DNA Damage Initiates Acute Lung Injury and Multi-Organ System Failure Evoked in Rats by Intra-Tracheal Pseudomonas Aeruginosa.
- DOI:10.1097/shk.0000000000000838
- 发表时间:2017-07
- 期刊:
- 影响因子:0
- 作者:Lee YL;Obiako B;Gorodnya OM;Ruchko MV;Kuck JL;Pastukh VM;Wilson GL;Simmons JD;Gillespie MN
- 通讯作者:Gillespie MN
Mitochondrial Damage-associated Molecular Patterns as Potential Biomarkers in DCD Heart Transplantation: Lessons From Myocardial Infarction and Cardiac Arrest.
- DOI:10.1097/txd.0000000000001265
- 发表时间:2022-01
- 期刊:
- 影响因子:2.3
- 作者:Longnus SL;Rutishauser N;Gillespie MN;Reichlin T;Carrel TP;Sanz MN
- 通讯作者:Sanz MN
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
MARK N GILLESPIE其他文献
MARK N GILLESPIE的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('MARK N GILLESPIE', 18)}}的其他基金
mtDNA damage and DAMPs in multiple organ dysfunction syndrome
多器官功能障碍综合征中的 mtDNA 损伤和 DAMP
- 批准号:
10092191 - 财政年份:2019
- 资助金额:
$ 41.84万 - 项目类别:
mtDNA damage and DAMPs in multiple organ dysfunction syndrome
多器官功能障碍综合征中的 mtDNA 损伤和 DAMP
- 批准号:
9921454 - 财政年份:2019
- 资助金额:
$ 41.84万 - 项目类别:
mtDNA damage and DAMPs in multiple organ dysfunction syndrome
多器官功能障碍综合征中的 mtDNA 损伤和 DAMP
- 批准号:
10353371 - 财政年份:2019
- 资助金额:
$ 41.84万 - 项目类别:
MtDNA repair: An isolated pharmacologic target in acute lung injury
MtDNA 修复:急性肺损伤的一个孤立的药理学靶点
- 批准号:
8276921 - 财政年份:2012
- 资助金额:
$ 41.84万 - 项目类别:
Mitochondrial DNA repair agents for acute lung injury
线粒体DNA修复剂治疗急性肺损伤
- 批准号:
9111928 - 财政年份:2012
- 资助金额:
$ 41.84万 - 项目类别:
MtDNA repair: An isolated pharmacologic target in acute lung injury
MtDNA 修复:急性肺损伤的一个孤立的药理学靶点
- 批准号:
9020265 - 财政年份:2012
- 资助金额:
$ 41.84万 - 项目类别:
MtDNA repair: An isolated pharmacologic target in acute lung injury
MtDNA 修复:急性肺损伤的一个孤立的药理学靶点
- 批准号:
8824557 - 财政年份:2012
- 资助金额:
$ 41.84万 - 项目类别:
MtDNA repair: An isolated pharmacologic target in acute lung injury
MtDNA 修复:急性肺损伤的一个孤立的药理学靶点
- 批准号:
8460071 - 财政年份:2012
- 资助金额:
$ 41.84万 - 项目类别:
Mitochondrial DNA repair agents for acute lung injury
线粒体DNA修复剂治疗急性肺损伤
- 批准号:
8313376 - 财政年份:2012
- 资助金额:
$ 41.84万 - 项目类别:
MtDNA repair: An isolated pharmacologic target in acute lung injury
MtDNA 修复:急性肺损伤的一个孤立的药理学靶点
- 批准号:
8610348 - 财政年份:2012
- 资助金额:
$ 41.84万 - 项目类别:
相似国自然基金
ACSS2介导的乙酰辅酶a合成在巨噬细胞组蛋白乙酰化及急性肺损伤发病中的作用机制研究
- 批准号:82370084
- 批准年份:2023
- 资助金额:48 万元
- 项目类别:面上项目
CDK4/6抑制下调衰老中性粒细胞促炎效应改善急性肺损伤的机制和干预研究
- 批准号:82302445
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
基于肺间充质干细胞源外泌体lncRNA表达谱差异探讨益气活血解毒法改善脓毒症急性肺损伤的机制
- 批准号:82374400
- 批准年份:2023
- 资助金额:51 万元
- 项目类别:面上项目
基于巨噬细胞炎性小体活化探究木犀草素治疗急性肺损伤的新机制
- 批准号:82374186
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
DUSP2介导自噬调控气管上皮细胞炎症在急性肺损伤中的机制研究
- 批准号:82360379
- 批准年份:2023
- 资助金额:32 万元
- 项目类别:地区科学基金项目
相似海外基金
Understanding Chirality at Cell-Cell Junctions With Microscale Platforms
利用微型平台了解细胞与细胞连接处的手性
- 批准号:
10587627 - 财政年份:2023
- 资助金额:
$ 41.84万 - 项目类别:
Neural Inflammation and Exercise Pressor Reflex in Heart Failure
心力衰竭中的神经炎症和运动升压反射
- 批准号:
10712202 - 财政年份:2023
- 资助金额:
$ 41.84万 - 项目类别:
Understanding and targeting fibroblast activation in influenza-triggered lung inflammation and post-viral disease
了解和靶向流感引发的肺部炎症和病毒后疾病中的成纤维细胞激活
- 批准号:
10717809 - 财政年份:2023
- 资助金额:
$ 41.84万 - 项目类别:
Combinatorial cytokine-coated macrophages for targeted immunomodulation in acute lung injury
组合细胞因子包被的巨噬细胞用于急性肺损伤的靶向免疫调节
- 批准号:
10648387 - 财政年份:2023
- 资助金额:
$ 41.84万 - 项目类别:
Mechanical signaling through the nuclear membrane in lung alveolar health
通过核膜的机械信号传导影响肺泡健康
- 批准号:
10677169 - 财政年份:2023
- 资助金额:
$ 41.84万 - 项目类别: